AR045258A1 - Un producto farmaceutico para inyeccion - Google Patents

Un producto farmaceutico para inyeccion

Info

Publication number
AR045258A1
AR045258A1 ARP040102886A ARP040102886A AR045258A1 AR 045258 A1 AR045258 A1 AR 045258A1 AR P040102886 A ARP040102886 A AR P040102886A AR P040102886 A ARP040102886 A AR P040102886A AR 045258 A1 AR045258 A1 AR 045258A1
Authority
AR
Argentina
Prior art keywords
container
injection
pharmaceutical product
closure
proton pump
Prior art date
Application number
ARP040102886A
Other languages
English (en)
Inventor
Rudolf Linder
Rita Lippert
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34216036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR045258(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of AR045258A1 publication Critical patent/AR045258A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D39/00—Closures arranged within necks or pouring openings or in discharge apertures, e.g. stoppers
    • B65D39/0005—Closures arranged within necks or pouring openings or in discharge apertures, e.g. stoppers made in one piece
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)

Abstract

Producto farmacéutico para inyección que comprende un contenedor que incluye un cierre adecuado para preparaciones inyectables, contenedor que contiene un inhibidor de bomba protónica lábil a ácidos, una sal del mismo, un solvato de un inhibidor de bomba protónica lábil a ácidos o una sal del mismo, donde el contenedor y el cierre están fabricados de un material que esencialmente no libera iones de zinc. Reivindicación 17: Un proceso para fabricar un producto farmacéutico para inyección de acuerdo con la reivindicación 1, proceso caracterizado porque comprende las etapas de a) proveer en el contenedor una mezcla del inhibidor de bomba protónica lábil a ácidos con un solvente y opcionalmente excipientes adicionales, b) someter al contenedor que comprende la mezcla precedente a liofilización y c) cerrar el contenedor con el cierre. Reivindicación 19: Un método para el tratamiento o prevención de un trastorno estomacal, caracterizado porque se emplea un producto de acuerdo con la reivindicación 1.
ARP040102886A 2003-08-21 2004-08-12 Un producto farmaceutico para inyeccion AR045258A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49671503P 2003-08-21 2003-08-21

Publications (1)

Publication Number Publication Date
AR045258A1 true AR045258A1 (es) 2005-10-19

Family

ID=34216036

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102886A AR045258A1 (es) 2003-08-21 2004-08-12 Un producto farmaceutico para inyeccion

Country Status (15)

Country Link
US (4) US20080167349A1 (es)
EP (1) EP1658073B1 (es)
JP (1) JP5006647B2 (es)
AR (1) AR045258A1 (es)
AT (1) ATE546141T1 (es)
AU (1) AU2004266076B2 (es)
CA (1) CA2535813C (es)
CY (1) CY1112764T1 (es)
DK (1) DK1658073T3 (es)
ES (1) ES2382932T3 (es)
PL (1) PL1658073T3 (es)
PT (1) PT1658073E (es)
SI (1) SI1658073T1 (es)
TW (1) TWI380817B (es)
WO (1) WO2005018639A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2513172A (en) * 2013-04-18 2014-10-22 Nupharm Lab Ltd Liquid dosage form and delivery system
DK3104905T3 (da) * 2014-02-12 2021-06-28 Sanofi Aventis Deutschland Lægemiddeladministrationsanordning med komprimerbart reservoir til væskeformigt medikament
CN104546743A (zh) * 2014-12-29 2015-04-29 成都通德药业有限公司 一种注射用质子泵抑制剂药品包装组合物及其制备方法
CN104546742A (zh) * 2014-12-29 2015-04-29 成都通德药业有限公司 一种注射用泮托拉唑钠药品及其制备方法
CN107773529B (zh) * 2016-08-24 2020-06-16 华仁药业股份有限公司 一种埃索美拉唑钠氯化钠注射液及其制备方法
US11642280B2 (en) 2020-11-10 2023-05-09 Corning Incorporated Glass containers and sealing assemblies for maintaining seal integrity at low storage temperatures
WO2022231885A1 (en) * 2021-04-26 2022-11-03 Corning Incorporated Container closure system and sealing assemblies for maintaining seal integrity at low storage temperatures
EP4396104B1 (en) 2021-08-31 2026-04-22 Corning Incorporated Container closure system and sealing assemblies for maintaining seal integrity at low storage temperatures
WO2023056464A1 (en) 2021-09-30 2023-04-06 Corning Incorporated Glass containers for storing pharmaceutical compositions
US12226370B2 (en) 2021-09-30 2025-02-18 Corning Incorporated Glass containers for storing pharmaceutical compositions
US12447106B2 (en) 2021-09-30 2025-10-21 Corning Incorporated Glass containers for storing pharmaceutical compositions
EP4436889A1 (en) 2021-11-22 2024-10-02 Corning Incorporated Cap designs for pharmaceutical container closure systems
CN119654147A (zh) * 2022-08-04 2025-03-18 江苏柯菲平医药股份有限公司 一种含有吡咯类胃酸分泌抑制剂的药物组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652751B1 (en) * 1992-07-28 1996-10-23 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
JP3954115B2 (ja) * 1992-07-28 2007-08-08 アストラゼネカ・アクチエボラーグ 注射剤および注射剤キット
TW426523B (en) * 1995-04-06 2001-03-21 Hoffmann La Roche Interferon solution
JP3193895B2 (ja) * 1996-11-07 2001-07-30 株式会社大協精工 医薬品容器用及び医薬品注入器用ゴム栓
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US5955575A (en) * 1997-12-22 1999-09-21 Hopital Sainte-Justine Antagonists of G-protein-coupled receptor
JP2000139880A (ja) * 1998-11-10 2000-05-23 Sekisui Chem Co Ltd 医療用栓体
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
JP2002209975A (ja) * 2001-01-19 2002-07-30 Daikyo Seiko Ltd 医薬バイアル用ラミネートゴム栓

Also Published As

Publication number Publication date
SI1658073T1 (sl) 2012-06-29
JP2007502803A (ja) 2007-02-15
ATE546141T1 (de) 2012-03-15
AU2004266076A1 (en) 2005-03-03
CA2535813A1 (en) 2005-03-03
US20120083512A1 (en) 2012-04-05
JP5006647B2 (ja) 2012-08-22
ES2382932T3 (es) 2012-06-14
PT1658073E (pt) 2012-05-09
EP1658073B1 (en) 2012-02-22
AU2004266076B2 (en) 2010-08-12
EP1658073A1 (en) 2006-05-24
PL1658073T3 (pl) 2012-07-31
DK1658073T3 (da) 2012-05-14
CA2535813C (en) 2013-10-22
WO2005018639A1 (en) 2005-03-03
CY1112764T1 (el) 2016-02-10
TW200522955A (en) 2005-07-16
TWI380817B (zh) 2013-01-01
US20080167349A1 (en) 2008-07-10
US20160324723A1 (en) 2016-11-10
US20090209591A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
UY27438A1 (es) Composición farmaceútica que comprende un conjugado oligómero-farmaco insulina, método para tratar deficiencia de insulina en un sujeto, método para proveer una composición farmacéutica.
MX386413B (es) Combinaciones terapéuticas que comprenden un inhibidor de raf y un inhibidor de erk.
CO5700796A2 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
AR105712A1 (es) Composiciones de insulina de rápida acción
AR024008A1 (es) Uso de microesferas biodegradables que liberan un agente anticancerigeno, para el tratamiento de glioblastoma, proceso para la preparacion de estasmicroesferas y suspension que contiene a las mismas
DE60120659D1 (de) Zusammensetzungen enthaltend carotenoide und deren verwendung zur verhinderung hormon-induzierter nebenwirkungen
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
CY1112764T1 (el) Φαρμακευτικο προϊον για ενεση
RU2018123666A (ru) Способ лечения рака у млекопитающего, включая человека, с примененим деплеции метионина и аспарагина
CO2022013167A2 (es) Composiciones y métodos para tratar o prevenir enfermedades inflamatorias que incluyen diabetes mellitus tipo i y tipo ii y enfermedades de la tiroides
NZ744233A (en) Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
Stanton et al. Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13
PE20230112A1 (es) Formulaciones de anticuerpos anti-tslp humanos y metodos de tratamiento de una enfermedad inflamatoria
CO5570658A2 (es) Composicion y metodo para el tratamiento de la diabetes
ATE477810T1 (de) Stabilisierte albumin-zubereitungen
ECSP066477A (es) Composición farmacéutica que comprende ácido (2r)-2-propiloctanoico como un ingrediente activo
AR039895A1 (es) Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla
DE69932922T2 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
CL2020001429A1 (es) Tratamiento del vsr con producto combinado.
US10149814B1 (en) Lactic acid topical composition and method of fabricating the same
NZ762110B2 (en) Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
Ricord et al. Impact of concurrent treatment with omeprazole on phenylbutazone-induced gastric ulceration in horses.
RU2574894C1 (ru) Способ лечения кожных заболеваний у животных
Kouřil et al. Artificial stripping of large mouth buffalo (Istiobus cyprinellus) using carp pituitary, GnRH analog and dopaminergic inhibitor Isofloxythepin
UA120764U (uk) Лікарський препарат знеболювальної та спазмолітичної дії "фентаніл"

Legal Events

Date Code Title Description
FC Refusal